Sectors:
Locations:
Min Investment:
Max Investment:
Target Investment:
2023
2023 - 2023
2023 - 2023
2020 - 2023
2022 - 2023
2020 - 2022
2018 - 2020
2018 - 2020
2016 - 2018
2016 - 2018
• Managed the records and progress of new fellows training, new invention disclosures, and licensing officer requests. • Assessed the patentability of inventions proposed by members of the University of Pennsylvania academic community that spanned topics such as diagnostic tools and techniques, therapeutics, biomedical devices, and digital applications. • Analyzed proposed inventions for qualities such as their innovation, marketability, and technical advancements in comparison to prior arts. • Assisted in the development of commercialization strategies for Penn technologies that ranged from theoretical designs to fully developed product prototypes and therapeutics.
2012 - 2018
2012 - 2018
I have my PhD. in the pharmacology with a focus on cardiovascular and hematologic pharmacology. My thesis work focused in a hematology lab working on modeling, analyzing, and treating various cardiovascular and hematologic pathologies using a human cell based microfluidic system. The pathologies include but are not limited to heparin induced thrombocytopenia and inflammatory induce thrombosis.
2015 - 2017
2016 - 2017
• As VP of Consulting, I directly trained and managed 16 project directors, 30 project managers, and 180+ team members of the PBG on the following skills to serve 30 diverse healthcare and biotech companies: client logistics, project scoping, team management, primary research, secondary research, and general consulting techniques. • Served on executive board sourcing committee that sourced 30 semester-long consulting projects for 200+ post-doctoral, master's, MBA, and Ph.D. students, serving real life clients that ranged from university start-ups to Fortune 500 medical device companies. • Lead the executive board staffing committee in collating and analyzing 200+ applications from potential project directors, project managers and team members to be staffed based on their prior experiences, education, and prior PBG team member evaluations. • Created, updated, implemented, and analyzed PBG surveys for inter-team evaluations, client feedback, and suggested improvements on PBG leadership and training. Survey results were utilized for project staffing, project sourcing, and improving PBG service to both students and clients.
2016 - 2016
• Directed 2 project managers whom each led 6-member teams in successfully completing consulting projects for a small pharma company developing a novel cancer therapeutic and a $10+ billion biotech company aiming to optimize their product training program. • Provided the pharmaceutical client with a market analysis and product development strategy resulting in the submission of an NIH SBIR grant application. • Provided the biotech client with a strategy based on primary research and the analysis of competitor programs resulting in a program overhaul to maximize training efficacy.
2016 - 2016
• Coordinated and developed a project scope with the client, a $20+ billion medical equipment company. • Led a 6-member team in performing in-depth case studies of five companies whom had successfully balanced their value and premium product brands in emerging markets. • Presented the client with a marketing strategy to achieve the greatest value in balancing their recently acquired value and premium brands in 3 emerging product markets.
2015 - 2015
• Operated on a 4-member team evaluating potential FDA hurdles for an early-stage startup developing two novel skin pigment altering therapeutics. • Offered the client potential pathology indications in pursuit of FDA approval, potential institutional funding sources, and strategies for enticing venture capitalist.
2014 - 2015
2015 - 2015
• Worked on a 6-member team for an early-stage pharmaceutical company advising on the most efficient path to market for a cardiovascular therapeutic with new drug indications. • Personally provided the client with marketing strategies to pursue FDA or supplement markets and for acquiring pre-clinical trial funding.
2014 - 2014
• Worked on a 4-member team, for a $10+ billion company, responsible for analyzing emerging markets and proposing device modifications to optimize their electrosurgical product portfolio against potential competitors. • Contributed an analysis of 40+ devices based on innovation, cost, and marketability culminating in three device modification strategies for entering three untapped, emerging markets.
2008 - 2012
2008 - 2012
As an undergraduate researcher, I assisted in the development and characterization of a novel continuous flow microfluidic immunoassay to be used in high risk surgical procedures.